-
1
-
-
0036182839
-
Cystoid macular edema associated with ocular hypotensive lipids
-
Wand M, Gaudio AR. Cystoid macular edema associated with ocular hypotensive lipids. Am J Ophthalmol. 2002;133:403-405.
-
(2002)
Am J Ophthalmol
, vol.133
, pp. 403-405
-
-
Wand, M.1
Gaudio, A.R.2
-
2
-
-
0033917235
-
A pooled-data analysis of three randomized, double-masked, six-month clinical studies comparing the intraocular pressure reducing effect of latanoprost and timolol
-
Hedman K, Alm A. A pooled-data analysis of three randomized, double-masked, six-month clinical studies comparing the intraocular pressure reducing effect of latanoprost and timolol. Eur J Ophthalmol. 2000;10:95-104.
-
(2000)
Eur J Ophthalmol
, vol.10
, pp. 95-104
-
-
Hedman, K.1
Alm, A.2
-
3
-
-
0034767649
-
Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure
-
Sherwood M, Brandt J; Bimatoprost Study Groups 1 and 2. Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure. Surv Ophthalmol. 2001;45(suppl 4):S361-S368.
-
(2001)
Surv Ophthalmol
, vol.45
, Issue.4 SUPPL.
-
-
Sherwood, M.1
Brandt, J.2
-
4
-
-
0034810344
-
Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension
-
Netland PA, Landry T, Sullivan EK, et al; Travoprost Study Group. Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension. Am J Ophthalmol. 2001;132:472-484.
-
(2001)
Am J Ophthalmol
, vol.132
, pp. 472-484
-
-
Netland, P.A.1
Landry, T.2
Sullivan, E.K.3
-
5
-
-
0036269833
-
The Ocular hypertension treatment study: A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma
-
Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701-713.
-
(2002)
Arch Ophthalmol
, vol.120
, pp. 701-713
-
-
Kass, M.A.1
Heuer, D.K.2
Higginbotham, E.J.3
-
6
-
-
0033808223
-
The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration
-
The AGIS Investigators
-
The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. The AGIS Investigators. Am J Ophthalmol. 2000;130:429-440.
-
(2000)
Am J Ophthalmol
, vol.130
, pp. 429-440
-
-
-
7
-
-
0032189255
-
Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures
-
Collaborative Normal-Tension Glaucoma Study Group
-
Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group. Am J Ophthalmol. 1998;126:487-497.
-
(1998)
Am J Ophthalmol
, vol.126
, pp. 487-497
-
-
-
8
-
-
0034765810
-
Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery
-
Lichter PR, Musch DC, Gillespie BW, et al; CIGTS Study Group. Interim clinical outcomes in the collaborative initial glaucoma treatment study comparing initial treatment randomized to medications or surgery. Ophthalmology. 2001;108:1943-1953.
-
(2001)
Ophthalmology
, vol.108
, pp. 1943-1953
-
-
Lichter, P.R.1
Musch, D.C.2
Gillespie, B.W.3
-
9
-
-
0036822851
-
Reduction of intraocular pressure and glaucoma progression: Results from the early manifest glaucoma Trial
-
Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M; Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma Trial. Arch Ophthalmol. 2002;120:1268-1279.
-
(2002)
Arch Ophthalmol
, vol.120
, pp. 1268-1279
-
-
Heijl, A.1
Leske, M.C.2
Bengtsson, B.3
Hyman, L.4
Bengtsson, B.5
Hussein, M.6
-
10
-
-
0037251618
-
Factors for glaucoma progression and the effect of treatment: The early manifest glaucoma trial
-
Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E; Early Manifest Glaucoma Trial Group. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121:48-56.
-
(2003)
Arch Ophthalmol
, vol.121
, pp. 48-56
-
-
Leske, M.C.1
Heijl, A.2
Hussein, M.3
Bengtsson, B.4
Hyman, L.5
Komaroff, E.6
-
11
-
-
0036269745
-
Answers from the ocular hypertension treatment study
-
Palmberg P. Answers from the ocular hypertension treatment study. Arch Ophthalmol. 2002;120: 829-830.
-
(2002)
Arch Ophthalmol
, vol.120
, pp. 829-830
-
-
Palmberg, P.1
-
12
-
-
84971580244
-
Absence of evidence is not evidence of absence
-
Altman DG, Bland JM. Absence of evidence is not evidence of absence. BMJ. 1995;311:485.
-
(1995)
BMJ
, vol.311
, pp. 485
-
-
Altman, D.G.1
Bland, J.M.2
-
13
-
-
0029588603
-
Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol
-
Scandinavian Latanoprost Study Group
-
Alm A, Stjernschantz J. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning. A comparison with timolol. Scandinavian Latanoprost Study Group. Ophthalmology. 1995;102:1743-1752.
-
(1995)
Ophthalmology
, vol.102
, pp. 1743-1752
-
-
Alm, A.1
Stjernschantz, J.2
-
14
-
-
0030023938
-
Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: A six-month masked, multicenter trial in the United States
-
The United States Latanoprost Study Group
-
Camras CB. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month masked, multicenter trial in the United States. The United States Latanoprost Study Group. Ophthalmology. 1996;103:138-147.
-
(1996)
Ophthalmology
, vol.103
, pp. 138-147
-
-
Camras, C.B.1
-
15
-
-
9044238840
-
A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension
-
The Latanoprost Study Group
-
Watson P, Stjernschantz J. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The Latanoprost Study Group. Ophthalmology. 1996;103:126-137.
-
(1996)
Ophthalmology
, vol.103
, pp. 126-137
-
-
Watson, P.1
Stjernschantz, J.2
-
16
-
-
0037404824
-
A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: A 12-week, randomized, masked-evaluator multicenter study
-
Parrish RK, Palmberg P, Sheu WP; XLT Study Group. A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study. Am J Ophthalmol. 2003;135:688-703.
-
(2003)
Am J Ophthalmol
, vol.135
, pp. 688-703
-
-
Parrish, R.K.1
Palmberg, P.2
Sheu, W.P.3
-
17
-
-
0034756982
-
Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: A 30-day comparison with latanoprost
-
DuBiner H, Cooke D, Dirks M, Stewart WC, VanDenburgh AM, Felix C. Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: a 30-day comparison with latanoprost. Surv Ophthalmol. 2001; 45(suppl 4):S353-S360.
-
(2001)
Surv Ophthalmol
, vol.45
, Issue.4 SUPPL.
-
-
Dubiner, H.1
Cooke, D.2
Dirks, M.3
Stewart, W.C.4
Vandenburgh, A.M.5
Felix, C.6
-
18
-
-
0034850210
-
Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension
-
Gandolfi S, Simmons ST, Sturm R, Chen K, VanDenburgh AM; Bimatoprost Study Group 3. Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension. Adv Ther. 2001;18:110-121.
-
(2001)
Adv Ther
, vol.18
, pp. 110-121
-
-
Gandolfi, S.1
Simmons, S.T.2
Sturm, R.3
Chen, K.4
VanDenburgh, A.M.5
-
19
-
-
0037215424
-
A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma
-
Noecker RS, Dirks MS, Choplin NT, Bernstein P, Batoosingh AL, Whitcup SM; Bimatoprost/ Latanoprost Study Group. A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma. Am J Ophthalmol. 2003;135:55-63.
-
(2003)
Am J Ophthalmol
, vol.135
, pp. 55-63
-
-
Noecker, R.S.1
Dirks, M.S.2
Choplin, N.T.3
Bernstein, P.4
Batoosingh, A.L.5
Whitcup, S.M.6
-
20
-
-
0035150975
-
A double-masked, randomized clinical trial comparing latanoprost with unoprostone in patients with open-angle glaucoma or ocular hypertension
-
Susanna R Jr, Giampani J Jr, Borges AS, Vessani RM, Jordao ML. A double-masked, randomized clinical trial comparing latanoprost with unoprostone in patients with open-angle glaucoma or ocular hypertension. Ophthalmology. 2001;108:259-263.
-
(2001)
Ophthalmology
, vol.108
, pp. 259-263
-
-
Susanna Jr., R.1
Giampani Jr., J.2
Borges, A.S.3
Vessani, R.M.4
Jordao, M.L.5
-
21
-
-
0036947024
-
A comparison of the fixed combination of latanoprost and timolol with its individual components
-
Pfeiffer N; European Latanoprost Fixed Combination Study Group. A comparison of the fixed combination of latanoprost and timolol with its individual components. Graefes Arch Clin Exp Ophthalmol. 2002;240:893-899.
-
(2002)
Graefes Arch Clin Exp Ophthalmol
, vol.240
, pp. 893-899
-
-
Pfeiffer, N.1
-
22
-
-
0036895931
-
Randomized clinical trial of latanoprost and unoprostone in patients with elevated intraocular pressure
-
Jampel HD, Bacharach J, Sheu WP, Wohl LG, Solish AM, Christie W; Latanoprost/Unoprostone Study Group. Randomized clinical trial of latanoprost and unoprostone in patients with elevated intraocular pressure. Am J Ophthalmol. 2002;134:863-871.
-
(2002)
Am J Ophthalmol
, vol.134
, pp. 863-871
-
-
Jampel, H.D.1
Bacharach, J.2
Sheu, W.P.3
Wohl, L.G.4
Solish, A.M.5
Christie, W.6
-
23
-
-
0029739619
-
A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study
-
Mishima HK, Masuda K, Kitazawa Y, Azuma I, Araie M. A comparison of latanoprost and timolol in primary open-angle glaucoma and ocular hypertension. A 12-week study. Arch Ophthalmol. 1996;114:929-932.
-
(1996)
Arch Ophthalmol
, vol.114
, pp. 929-932
-
-
Mishima, H.K.1
Masuda, K.2
Kitazawa, Y.3
Azuma, I.4
Araie, M.5
-
24
-
-
0033971519
-
Efficacy and safety of latanoprost eye drops for glaucoma treatment: A 1-year study in Japan
-
Suzuki M, Mishima HK, Masuda K, Araie M, Kitazawa Y, Azuma I. Efficacy and safety of latanoprost eye drops for glaucoma treatment: a 1-year study in Japan. Jpn J Ophthalmol. 2000; 44:33-38.
-
(2000)
Jpn J Ophthalmol
, vol.44
, pp. 33-38
-
-
Suzuki, M.1
Mishima, H.K.2
Masuda, K.3
Araie, M.4
Kitazawa, Y.5
Azuma, I.6
-
25
-
-
0035002436
-
A randomized double-masked crossover study comparing latanoprost 0.005% with unoprostone 0.12% in patients with primary open-angle glaucoma and ocular hypertension
-
Aung T, Chew PT, Yip CC, et al. A randomized double-masked crossover study comparing latanoprost 0.005% with unoprostone 0.12% in patients with primary open-angle glaucoma and ocular hypertension. Am J Ophthalmol. 2001;131:636-642.
-
(2001)
Am J Ophthalmol
, vol.131
, pp. 636-642
-
-
Aung, T.1
Chew, P.T.2
Yip, C.C.3
-
26
-
-
0035014907
-
The efficacy and safety of latanoprost 0.005% once daily versus brimonidine 0.2% twice daily in open-angle glaucoma or ocular hypertension
-
Stewart WC, Day DG, Stewart JA, Schuhr J, Latham KE. The efficacy and safety of latanoprost 0.005% once daily versus brimonidine 0.2% twice daily in open-angle glaucoma or ocular hypertension. Am J Ophthalmol. 2001;131:631-635.
-
(2001)
Am J Ophthalmol
, vol.131
, pp. 631-635
-
-
Stewart, W.C.1
Day, D.G.2
Stewart, J.A.3
Schuhr, J.4
Latham, K.E.5
-
27
-
-
0037532748
-
Bimatoprost 0.03% versus travoprost 0.004% in black Americans with glaucoma or ocular hypertension
-
Noecker RJ, Earl ML, Mundorf T, Peace J, Williams RD. Bimatoprost 0.03% versus travoprost 0.004% in black Americans with glaucoma or ocular hypertension. Adv Ther. 2003;20:121-128.
-
(2003)
Adv Ther
, vol.20
, pp. 121-128
-
-
Noecker, R.J.1
Earl, M.L.2
Mundorf, T.3
Peace, J.4
Williams, R.D.5
-
28
-
-
0036822173
-
One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension
-
Higginbotham EJ, Schuman JS, Goldberg I, et al; Bimatoprost Study Groups 1 and 2. One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension. Arch Ophthalmol. 2002;120:1286-1293.
-
(2002)
Arch Ophthalmol
, vol.120
, pp. 1286-1293
-
-
Higginbotham, E.J.1
Schuman, J.S.2
Goldberg, I.3
-
29
-
-
0036668996
-
Bimatoprost and travoprost: A review of recent studies of two new glaucoma drugs
-
Eisenberg DL, Toris CB, Camras CB. Bimatoprost and travoprost: a review of recent studies of two new glaucoma drugs. Surv Ophthalmol. 2002;47(suppl 1):S105-S115.
-
(2002)
Surv Ophthalmol
, vol.47
, Issue.1 SUPPL.
-
-
Eisenberg, D.L.1
Toris, C.B.2
Camras, C.B.3
-
30
-
-
85047053750
-
Latanoprost versus bimatoprost
-
Eisenberg D. Latanoprost versus bimatoprost. Ophthalmology. 2003;110:1861-1862.
-
(2003)
Ophthalmology
, vol.110
, pp. 1861-1862
-
-
Eisenberg, D.1
-
31
-
-
0033917235
-
A pooled-data analysis of three randomized, double-masked, six-month clinical studies comparing the intraocular pressure reducing effect of latanoprost and timolol
-
Hedman K, Alm A. A pooled-data analysis of three randomized, double-masked, six-month clinical studies comparing the intraocular pressure reducing effect of latanoprost and timolol. Eur J Ophthalmol. 2000;10:95-104.
-
(2000)
Eur J Ophthalmol
, vol.10
, pp. 95-104
-
-
Hedman, K.1
Alm, A.2
-
32
-
-
0034986538
-
Comparison of once- Or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP: A 3-month clinical trial
-
Brandt JD, VanDenburgh AM, Chen K, Whitcup SM; Bimatoprost Study Group. Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP: a 3-month clinical trial. Ophthalmology. 2001;108:1023-1031.
-
(2001)
Ophthalmology
, vol.108
, pp. 1023-1031
-
-
Brandt, J.D.1
Vandenburgh, A.M.2
Chen, K.3
Whitcup, S.M.4
-
33
-
-
0037233109
-
A randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertension
-
Whitcup SM, Cantor LB, VanDenburgh AM, Chen K. A randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertension. Br J Ophthalmol. 2003;87:57-62.
-
(2003)
Br J Ophthalmol
, vol.87
, pp. 57-62
-
-
Whitcup, S.M.1
Cantor, L.B.2
Vandenburgh, A.M.3
Chen, K.4
-
34
-
-
0035990084
-
A retrospective review of non-responders to latanoprost
-
Scherer WJ. A retrospective review of non-responders to latanoprost. J Ocul Pharmacol Ther. 2002;18:287-291.
-
(2002)
J Ocul Pharmacol Ther
, vol.18
, pp. 287-291
-
-
Scherer, W.J.1
-
35
-
-
0036880790
-
Efficacy of bimatoprost in glaucoma and ocular hypertension unresponsive to latanoprost
-
Williams RD. Efficacy of bimatoprost in glaucoma and ocular hypertension unresponsive to latanoprost. Adv Ther. 2002;19:275-281.
-
(2002)
Adv Ther
, vol.19
, pp. 275-281
-
-
Williams, R.D.1
-
36
-
-
0037370463
-
Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost
-
Gandolfi SA, Cimino L. Effect of bimatoprost on patients with primary open-angle glaucoma or ocular hypertension who are nonresponders to latanoprost. Ophthalmology. 2003;110:609-614.
-
(2003)
Ophthalmology
, vol.110
, pp. 609-614
-
-
Gandolfi, S.A.1
Cimino, L.2
-
37
-
-
0037653724
-
Multicenter, open-label evaluation of hyperemia associated with use of bimatoprost in adults with open-angle glaucoma or ocular hypertension
-
Abelson MB, Mroz M, Rosner SA, Dirks MS, Hirabayashi D. Multicenter, open-label evaluation of hyperemia associated with use of bimatoprost in adults with open-angle glaucoma or ocular hypertension. Adv Ther. 2003;20:1-13.
-
(2003)
Adv Ther
, vol.20
, pp. 1-13
-
-
Abelson, M.B.1
Mroz, M.2
Rosner, S.A.3
Dirks, M.S.4
Hirabayashi, D.5
|